NCT03005535

Brief Summary

This will be a randomized clinical trial carried out on subjects with suboptimal control of cholesterolemia who will consume 30 g per day of a vitaminized corn oil (plus B6 and E vitamins), in order to evaluate the effects on lipid profile, endothelial function and PCSK9

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2016

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 29, 2016

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

December 29, 2016

Status Verified

December 1, 2016

Enrollment Period

4 months

First QC Date

December 5, 2016

Last Update Submit

December 25, 2016

Conditions

Outcome Measures

Primary Outcomes (3)

  • Endothelial function (measured by Endocheck) change from the baseline to the end of the intervention period

    At the beginning and after 8 weeks of both intervention periods (up to 24 weeks)

  • 12 hour fasting lipid profile change from the baseline to the end of the intervention period

    At the first visit (run-in) at the beginning, after 4 and 8 weeks of both intervention periods (up to 24 weeks)

  • PCSK9 levels change from the baseline to the end of the intervention period

    At the beginning and after 8 weeks of both intervention periods (up to 24 weeks)

Secondary Outcomes (3)

  • Inflammatory markers (high sensitivity C reactive protein hs-PCR, malondialdehyde MDA, homocysteine) change from the baseline to the end of the intervention period

    At the beginning and after 8 weeks of both intervention periods (up to 24 weeks)

  • Blood pressure change from the baseline to the end of the intervention period

    6 months

  • Fatty acid profile of whole blood total lipids change from the baseline to the end of the intervention period

    At the beginning and after 8 weeks of both intervention periods (up to 24 weeks)

Study Arms (2)

Vitaminized corn oil

ACTIVE COMPARATOR

Vitaminized corn oil (plus B6 and E vitamins), 30 g per day, per 8 weeks, with meals (15 g per meal)

Other: Vitaminized corn oil

Olive oil

PLACEBO COMPARATOR

Olive oil (not extra-virgin), 30 g per day, per 8 weeks, with meals (15 g per meal)

Other: Olive oil

Interventions

Oil consumption at the two main meals, lunch and dinner (15gx2 per day)

Vitaminized corn oil

Oil consumption at the two main meals, lunch and dinner (15gx2 per day)

Olive oil

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Total cholesterol between 200 and 280 mg/dL and/or LDL cholesterol between 130 and 190 mg/dL
  • Triglycerides lower than 200 mg/dL
  • Cardiovascular risk at 10 years lower than 10%
  • Informed consent

You may not qualify if:

  • Secundary prevention for cardiovascular diseases
  • BMI higher than 30
  • Assumption of lipid lowering drug or supplement
  • Alcohol abuse
  • Alterations in thyroid, liver or kidney functions, muscle diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

S. Orsola-Malpighi University Hospital

Bologna, BO, 40138, Italy

Location

MeSH Terms

Conditions

Atherosclerosis

Interventions

Olive Oil

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Dietary Fats, UnsaturatedDietary FatsFatsLipidsFats, UnsaturatedPlant OilsOilsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Internal Medicine Unit

Study Record Dates

First Submitted

December 5, 2016

First Posted

December 29, 2016

Study Start

October 1, 2016

Primary Completion

February 1, 2017

Study Completion

November 1, 2017

Last Updated

December 29, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will share

Locations